scispace - formally typeset
Journal ArticleDOI

Scleroderma renal crisis

TLDR
More than 60 years after its initial description, SRC still remains an important cause of morbidity and mortality in scleroderma and the prognosis of SRC has improved substantially.
About
This article is published in Seminars in Arthritis and Rheumatism.The article was published on 2015-06-01. It has received 92 citations till now. The article focuses on the topics: Scleroderma Renal Crisis & Scleroderma.

read more

Citations
More filters
Journal ArticleDOI

Systemic lupus erythematosus and systemic sclerosis: All roads lead to platelets.

TL;DR: The main pathogenic implications of platelet activation in both systemic sclerosis and systemic lupus erythematosus are understood and potential therapeutics targeting platelets are discussed.
Journal ArticleDOI

Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.

TL;DR: Late scleroderma patterns in NVC are the best independent predictors of SSc patients who are at risk of developing Raynaud's phenomenon and digital ulcers and endothelial dysfunction assessed by FMD and ET-1 was found to be an independent predictor of DU recurrence in a 3-year follow-up.
Journal ArticleDOI

Diagnostic criteria, severity classification and guidelines of systemic sclerosis.

TL;DR: The clinical guideline was established by clinical questions based on evidence‐based medicine according to the New Minds Clinical Practice Guideline Creation Manual and aimed to make the guideline easy to use and reliable based on the newest evidence.
Journal ArticleDOI

The Frequency of Scleroderma Renal Crisis over Time: A Metaanalysis

TL;DR: It appears that SRC remains uncommon in lcSSc and the rate in the dcSSc group may be stable over time, and increasing awareness of SRC could lead to higher rates in more recent years and/or better survival from SRC, but this was not observed.
References
More filters
Journal ArticleDOI

Changes in causes of death in systemic sclerosis, 1972-2002.

TL;DR: The change in the pattern of scleroderma-related deaths over the past 30 years demonstrates that the lung (both pulmonary hypertension and PF) is the primary cause of sclerosis- related deaths today.
Journal ArticleDOI

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

TL;DR: The clinical distinction seemed to be superseded by an antibody-based classification in predicting some scleroderma complications, and the EUSTAR MEDS database facilitates the analysis of clinical patterns in SSc, and contributes to the standardised assessment and monitoring of SSc internationally.
Journal ArticleDOI

Autoantibodies in systemic sclerosis.

TL;DR: In this article, the authors describe the clinical, laboratory, and prognostic features associated with the scleroderma-specific autoantibodies, including demographic, clinical features, organ system outcomes, and survival within the patients with a specific antibody.
Journal ArticleDOI

Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis

TL;DR: This retrospective case-control study has shown a significant association between antecedent high-dose corticosteroid therapy and the development of scleroderma renal crisis (SRC), and should discourage the use of high-drugs in patients with early diffuse SRC who are at increased risk of developing SRC.
Journal ArticleDOI

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

TL;DR: Improved survival and successful discontinuation of dialysis are possible when ACE inhibitors are used to treat scleroderma renal crisis and patients with systemic sclerosis who develop hypertension should be treated with an ACE inhibitor.
Related Papers (5)

2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

Frank H J van den Hoogen, +46 more